Status:

NOT_YET_RECRUITING

STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes

Lead Sponsor:

Sunnybrook Health Sciences Centre

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Type 2 Diabetes Mellitus

Medication Adherence

Eligibility:

All Genders

25-64 years

Phase:

NA

Brief Summary

Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Import...

Detailed Description

Previous research has found that lowering patients' out-of-pocket costs has a positive impact on health service utilization, risk factor control and patient-reported health for many chronic diseases, ...

Eligibility Criteria

Inclusion

  • clinical diagnosis of type 2 diabetes record in family physician's electronic medical record
  • lack of medication insurance

Exclusion

  • \-

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT03804905

Start Date

January 1 2026

End Date

December 31 2026

Last Update

December 24 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes | DecenTrialz